PTC Therapeutics, Inc.
PTC Therapeutics, Inc. scores highest on Torque (99) and lowest on Price (0). Its PosiPenta is 57.52 out of 100, around the middle of similar companies.
On the Penta Grid this week, PTC Therapeutics, Inc. is Grid #172 of 837 in the Healthcare sector in United States, and Grid #910 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| PTC Therapeutics, Inc. | 57.52 | 0 | 77 | 43 | 99 | 68 |
| Haemonetics Corporation | 61.80 | 19 | 88 | 96 | 49 | 58 |
| Sotera Health Company | 57.92 | 29 | 77 | 88 | 50 | 46 |
| Oruka Therapeutics, Inc. | 43.46 | 16 | 22 | 68 | 74 | 38 |
| MiniMed Group, Inc. | 63.68 | 35 | 63 | 72 | 71 | 77 |
| Kodiak Sciences Inc. | 35.29 | 1 | 26 | 87 | 15 | 49 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -91.14 |
| P/B ratio | -29.90 |
EEarnings
| Trailing EPS | ₹-61.56 |
| Forward EPS | ₹224.47 |
NNitro
| Price | 5610.91 |
| 52-week high | 8606.75 |
| 52-week low | 5569.24 |
| Fall from 52-week high | 34.8% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -13.19 |
AAnchor
| Beta (price swings) | 0.49 |
| Market cap | ₹46,829 Cr |
| Insider holding | 7.31% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is PTC Therapeutics, Inc.'s PosiPenta score?
PTC Therapeutics, Inc.'s PosiPenta is 57.52 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does PTC Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, PTC Therapeutics, Inc. is Grid #172 of 837 in the Healthcare sector in United States, and Grid #910 of 4,000 in United States.
Which PosiPenta pillar is strongest for PTC Therapeutics, Inc.?
Torque (durability), with a score of 99 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for PTC Therapeutics, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has PTC Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 11.42 points, from 46.10 to 57.52.
PositoAI is for research and education only and is not investment advice.